Methodological Characteristics of Clinical Trials Supporting the Marketing Authorisation of Advanced Therapies in the European Union
Several advanced therapy medicinal products (ATMPs) have been approved in the European Union (EU). The aim of this study is to analyse the methodological features of the clinical trials (CT) that supported the marketing authorization (MA) of the approved ATMPs in the EU. A systematic review of the c...
Guardado en:
Autores principales: | Carolina Iglesias-Lopez, Antònia Agustí, Antonio Vallano, Merce Obach |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/77ef42e3a7644035a068caa9e761def1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Current landscape of clinical development and approval of advanced therapies
por: Carolina Iglesias-Lopez, et al.
Publicado: (2021) -
Investigación y desarrollo de nuevos medicamentos: de la molécula al fármaco
por: Marovac,Jacqueline
Publicado: (2001) -
New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy
por: Lundstrom K
Publicado: (2018) -
Registration, publication, and outcome reporting among pivotal clinical trials that supported FDA approval of high-risk cardiovascular devices before and after FDAAA
por: Matthew J. Swanson, et al.
Publicado: (2021) -
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. Special Article: Advanced therapy medicinal products in Brazil: regulatory panorama
por: João Batista Silva Junior, et al.
Publicado: (2021)